blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1458673

EP1458673 - SUBSTITUTED PHENYLPROPIONIC ACID DERIVATIVES AS AGONISTS TO HUMAN PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR ALPHA (PPAR) [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  13.07.2007
Database last updated on 03.01.2025
Most recent event   Tooltip05.10.2007Change - lapse in a contracting state
State(s) deleted from list of lapses: IT
published on 07.11.2007  [2007/45]
Applicant(s)For all designated states
AstraZeneca AB
151 85 Södertälje / SE
[N/P]
Former [2006/36]For all designated states
AstraZeneca AB
Sodertalje
151 85 / SE
Former [2004/39]For all designated states
Astrazeneca AB
Sodertalje
151 85 / SE
Inventor(s)01 / ALSTERMARK LINDSTEDT, Eva-Lotte
Molndal
S-431 83 / SE
02 / OLSSON, Anna, Christina
Molndal
S-431 83 / SE
03 / LI, Lanna
Molndal
S-431 83 / SE
 [2004/39]
Application number, filing date02804964.118.12.2002
[2004/39]
WO2002GB05738
Priority number, dateSE2001000433419.12.2001         Original published format: SE 0104334
[2004/39]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO03051821
Date:26.06.2003
Language:EN
[2003/26]
Type: A1 Application with search report 
No.:EP1458673
Date:22.09.2004
Language:EN
The application published by WIPO in one of the EPO official languages on 26.06.2003 takes the place of the publication of the European patent application.
[2004/39]
Type: B1 Patent specification 
No.:EP1458673
Date:06.09.2006
Language:EN
[2006/36]
Search report(s)International search report - published on:EP26.06.2003
ClassificationIPC:C07C235/20, A61K31/16, A61P3/00
[2004/39]
CPC:
A61K31/16 (EP,KR,US); C07C235/20 (EP,KR,US); A61K31/195 (EP,US);
A61K45/06 (EP,US); A61P13/12 (EP); A61P15/00 (EP);
A61P15/08 (EP); A61P25/00 (EP); A61P25/16 (EP);
A61P25/28 (EP); A61P27/02 (EP); A61P3/00 (EP);
A61P3/04 (EP); A61P3/06 (EP); A61P3/10 (EP);
A61P35/00 (EP); A61P43/00 (EP); A61P5/48 (EP);
A61P5/50 (EP); A61P9/04 (EP); A61P9/10 (EP);
A61P9/12 (EP); A61P9/14 (EP); C07C2601/14 (EP,US);
Y02P20/55 (EP,US) (-)
C-Set:
A61K31/16, A61K2300/00 (EP,US);
A61K31/195, A61K2300/00 (US,EP)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE,   SI,   SK,   TR [2004/39]
Extension statesAL19.07.2004
LT19.07.2004
LV19.07.2004
MK19.07.2004
RO19.07.2004
TitleGerman:SUBSTITUIERTE PHENYLPROPIONSÄUREDERIVATE ALS AGONISTEN FÜR DEN HUMANEN PEROXISOMPROLIFERATORAKTIVIERTEN REZEPTOR ALPHA (PPAR)[2004/39]
English:SUBSTITUTED PHENYLPROPIONIC ACID DERIVATIVES AS AGONISTS TO HUMAN PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR ALPHA (PPAR)[2004/39]
French:DERIVES SUBSTITUES DE L'ACIDE PHENYLPROPIONIQUE COMME AGONISTES AU RECEPTEUR ALPHA ACTIVE PAR PROLIFERATEUR DE PEROXYSOME HUMAIN[2004/39]
Entry into regional phase19.07.2004National basic fee paid 
19.07.2004Designation fee(s) paid 
19.07.2004Examination fee paid 
Examination procedure17.06.2003Request for preliminary examination filed
International Preliminary Examining Authority: EP
19.07.2004Examination requested  [2004/39]
17.11.2004Despatch of a communication from the examining division (Time limit: M04)
16.03.2005Reply to a communication from the examining division
16.02.2006Despatch of a communication from the examining division (Time limit: M02)
06.04.2006Reply to a communication from the examining division
15.05.2006Communication of intention to grant the patent
21.07.2006Fee for grant paid
21.07.2006Fee for publishing/printing paid
Opposition(s)07.06.2007No opposition filed within time limit [2007/33]
Fees paidRenewal fee
03.01.2005Renewal fee patent year 03
02.01.2006Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  Tooltipdeleted
[2007/45]
Former [2007/39]IT06.09.2006
Cited inInternational search[A]JP2001261612  ;
 [A]WO0059889  (SANKYO CO [JP], et al) [A] 1,5,7,12 * abstract *;
 [A]WO0061582  (SANKYO CO [JP], et al) [A] 1,5,7,11,12 * abstract *;
 [A]WO0075103  (KYORIN SEIYAKU KK [JP], et al) [A] 1,5,7,12 * abstract *;
 [AP]WO0244130  (KYORIN SEIYAKU KK [JP], et al) [AP] 1,5,7,12 * abstract *;
 [AP]WO0244127  (KYORIN SEIYAKU KK [JP], et al) [AP] 1,5,7,12 * abstract *;
 [AP]WO02083616  (SANKYO CO [JP], et al) [AP] 1,5,7,12* abstract *
 [A]  - PATENT ABSTRACTS OF JAPAN, (20020701), vol. 2000, no. 26, & JP2001261612 A 20010926 (MITSUI CHEMICALS INC) [A] 1,5,7,12 * abstract *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.